Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Kommalapati · SciRah

Researcher profile · Semantic Scholar

A. Kommalapati

Share profile

A. Kommalapati — researcher profile on SciRah

h-index: 21
Works: 94
Citations: 1,641

Most-cited papers

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
A. Kommalapati, S. Tella, M. Borad, M. Javle +1 more
2021Cancers148 citations Open access
Semantic Scholar
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes.
A. Kommalapati, S. Tella, M. Durkin, R. Go +1 more
2018Blood128 citations Open access
Semantic Scholar
Contemporary Management of Localized Resectable Pancreatic Cancer
A. Kommalapati, S. Tella, G. Goyal, Wen W. Ma +1 more
2018Cancers87 citations Open access
Semantic Scholar
Anti–PD-L1 Treatment Induced Central Diabetes Insipidus
Chen Zhao, S. Tella, J. del Rivero, A. Kommalapati +4 more
2017Journal of Clinical Endocrinology and Metabolism80 citations Open access
Semantic Scholar
Second-line therapies in advanced biliary tract cancers.
S. Tella, A. Kommalapati, M. Borad, A. Mahipal
2020The Lancet Oncology78 citations
Semantic Scholar
FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma.
A. Mahipal, S. Tella, A. Kommalapati, D. Anaya +1 more
2019Cancer Treatment Reviews70 citations
Semantic Scholar
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database
S. Tella, A. Kommalapati, S. Yaturu, E. Kebebew
2018Journal of Clinical Endocrinology and Metabolism68 citations Open access
Semantic Scholar
Change in patients’ perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma
A. Barata, A. Hoogland, A. Kommalapati, J. Logue +16 more
2022Transplantation and Cellular Therapy58 citations Open access
Semantic Scholar
Prevention and treatment of FGFR inhibitor-associated toxicities.
A. Mahipal, S. Tella, A. Kommalapati, James Yu +1 more
2020Critical reviews in oncology/hematology57 citations
Semantic Scholar
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma.
Hamza Hashmi, A. Mirza, Alicia Darwin, C. Logothetis +14 more
2020Blood Advances56 citations Open access
Semantic Scholar
Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
S. Tella, A. Kommalapati, R. Correa
2017Cureus48 citations Open access
Semantic Scholar
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.
S. Chakrabarti, S. Tella, A. Kommalapati, B. M. Huffman +8 more
2019Journal of Gastrointestinal Oncology47 citations Open access
Semantic Scholar
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
A. Mahipal, S. Tella, A. Kommalapati, Alexander S. Lim +1 more
2019Cancers47 citations Open access
Semantic Scholar
Novel targeted treatment options for advanced cholangiocarcinoma
A. Mahipal, A. Kommalapati, S. Tella, Alexander S. Lim +1 more
2018Expert Opinion on Investigational Drugs46 citations
Semantic Scholar
Change in neurocognitive performance among patients with non-Hodgkin’s lymphoma in the first year after CAR T-cell therapy
A. Hoogland, A. Barata, J. Logue, A. Kommalapati +16 more
2022Transplantation and Cellular Therapy41 citations Open access
Semantic Scholar
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
C. O'Sullivan, K. Ballman, L. McCall, A. Kommalapati +13 more
2021Future Oncology32 citations Open access
Semantic Scholar
Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma
A. Kommalapati, S. Tella, R. Go, G. Goyal
2018Leukemia and Lymphoma26 citations
Semantic Scholar
Natural Killer/T‐cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States
A. Kommalapati, S. Tella, A. Ganti, J. Armitage
2018Clinical Lymphoma, Myeloma & Leukemia25 citations
Semantic Scholar
Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
G. Goyal, A. Kommalapati, A. Bartley, T. Gunderson +2 more
2018Lung Cancer24 citations
Semantic Scholar
Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy
A. Barata, A. Hoogland, K. Hyland, A. Otto +13 more
2021Psycho-Oncology22 citations Open access
Semantic Scholar
Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival.
S. Tella, A. Kommalapati, S. Yadav, J. Bergquist +6 more
2020European Journal of Surgical Oncology22 citations
Semantic Scholar
A Novel Clinically Based Staging System for Gallbladder Cancer.
S. Yadav, S. Tella, A. Kommalapati, Kristin Mara +8 more
2020The Journal of the National Comprehensive Cancer Network21 citations
Semantic Scholar
Fluoroquinolone-associated suicide.
A. Kommalapati, Sara Wallam, S. Tella, Z. Qureshi +1 more
2018European journal of internal medicine19 citations
Semantic Scholar
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date
S. Tella, A. Mahipal, A. Kommalapati, Zhao-Hui Jin
2019OncoTargets and Therapy18 citations Open access
Semantic Scholar
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
S. Tella, A. Kommalapati, A. Mahipal, Zhao-Hui Jin
2022Biomedicines17 citations Open access
Semantic Scholar
Survival and prognostic factors in patients with rectal squamous cell carcinoma.
A. Kommalapati, S. Tella, S. Yadav, G. Goyal +4 more
2020European Journal of Surgical Oncology17 citations
Semantic Scholar
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition
S. Tella, A. Kommalapati
2015Cureus17 citations Open access
Semantic Scholar
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Brian J. Chen, S. Nagai, J. Armitage, Bartlett J. Witherspoon +20 more
2019The Oncologist16 citations Open access
Semantic Scholar
Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
S. Tella, A. Kommalapati, S. Yadav, J. Bergquist +6 more
2019European Journal of Surgical Oncology16 citations
Semantic Scholar
Immune Check Point Inhibitors in Cancer Therapy: Beware of “Friendly Fire” Effect
A. Kommalapati, Shanaz Sikder, S. Tella
2017Research & reviews. Journal of hospital and clinical pharmacy16 citations
Semantic Scholar
Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma.
A. Kommalapati, S. Tella, G. Goyal, M. Borad +6 more
2019HPB15 citations Open access
Semantic Scholar
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States.
S. Tella, A. Kommalapati, Karen L. Rech, R. Go +1 more
2019Clinical Lymphoma, Myeloma & Leukemia15 citations
Semantic Scholar
Evaluation and management of skeletal disease in cancer care
A. Kommalapati, S. Tella, M. Esquivel, Ricardo G. Correa
2017Critical reviews in oncology/hematology15 citations Open access
Semantic Scholar
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies.
S. Tella, A. Kommalapati, A. Mahipal
2020Chinese Clinical Oncology14 citations Open access
Semantic Scholar
A population‐based analysis of second primary malignancies in T‐cell neoplasms
A. Kommalapati, S. Tella, R. Go, N. Bennani +1 more
2018British Journal of Haematology14 citations Open access
Semantic Scholar
T cell/histiocyte‐rich large B cell lymphoma: incidence, demographic disparities, and long‐term outcomes
A. Kommalapati, S. Tella, R. Go, G. Nowakowski +1 more
2018British Journal of Haematology14 citations Open access
Semantic Scholar
Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
A. Mahipal, S. Tella, A. Kommalapati, G. Goyal +5 more
2018Investigational new drugs13 citations Open access
Semantic Scholar
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma.
S. Tella, A. Kommalapati, A. Ganti, A. Marr
2019The Journal of the National Comprehensive Cancer Network12 citations Open access
Semantic Scholar
Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
A. Kommalapati, S. Tella, A. Appiah, L. Smith +1 more
2019The Journal of the National Comprehensive Cancer Network12 citations Open access
Semantic Scholar
Immune‐related hematologic adverse events in the context of immune checkpoint inhibitor therapy
Antoine N. Saliba, Zhuoer Xie, A. Higgins, X. Andrade-Gonzalez +21 more
2021American journal of hematology/oncology11 citations Open access
Semantic Scholar
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
R. Mehta, A. Kommalapati, R. Kim
2020Cancer Management and Research11 citations Open access
Semantic Scholar
Molecular-Targeted Therapies in Hepatocellular Carcinoma
A. Mahipal, A. Kommalapati, R. Mehta, R. Kim
2019Molecular and Translational Medicine11 citations
Semantic Scholar
A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer
A. Kommalapati, S. Tella, G. Goyal, A. Ganti +2 more
2018Breast Cancer Research and Treatment11 citations
Semantic Scholar
Potential Role of Metabolic Intervention in the Management of Advanced Differentiated Thyroid Cancer
S. Tella, A. Kommalapati, M. Esquivel, Ricardo G. Correa
2017Frontiers in Oncology10 citations Open access
Semantic Scholar
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
M. Storandt, A. Mahipal, S. Tella, A. Kommalapati +1 more
2022Journal of Hepatocellular Carcinoma8 citations Open access
Semantic Scholar
Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
A. Kommalapati, T. Tanvetyanon
2020Human Vaccines & Immunotherapeutics7 citations Open access
Semantic Scholar
Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene
A. Kommalapati, A. Kallam, J. Krishnamurthy, S. Tella +2 more
2018Cureus7 citations Open access
Semantic Scholar
Economic Cost and Sustainability of Oral Therapies in Precision Oncology
A. Desai, C. Scheckel, Leah C. Soderberg, Chelsee J. Jensen +7 more
2022JCO Oncology Practice6 citations
Semantic Scholar
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies
Zhuoer Xie, Antoine N. Saliba, J. Abeykoon, U. Majeed +25 more
2021JCO Oncology Practice6 citations Open access
Semantic Scholar
Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents
N. Brenner, A. Kommalapati, Muhammad Ahsan, A. Ganguli
2019JN. Journal of Nephrology (Milano. 1992)6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Tella×39
Invite
S. Tella — researcher profile on SciRah
A. Mahipal×20
Invite
A. Mahipal — researcher profile on SciRah
G. Goyal×13
Invite
G. Goyal — researcher profile on SciRah
R. Kim×7
Invite
R. Kim — researcher profile on SciRah

×6

Invite

R. Go — researcher profile on SciRah

Invite

M. Borad — researcher profile on SciRah

Invite

S. Yadav — researcher profile on SciRah

Invite

S. Cleary — researcher profile on SciRah

Invite

M. Jain — researcher profile on SciRah

Invite

F. Locke — researcher profile on SciRah

Invite

Lori Durgin — researcher profile on SciRah

Zhao-Hui Jin×4

Invite

Zhao-Hui Jin — researcher profile on SciRah